XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Conversion of Class C Common Stock to Class A Common Stock
Class A
Common Stock
Class A
Common Stock
Class A
Conversion of Class C Common Stock to Class A Common Stock
Common Stock
Class C
Conversion of Class C Common Stock to Class A Common Stock
Common Stock
Class C
Additional Paid-In Capital
Additional Paid-In Capital
Conversion of Class C Common Stock to Class A Common Stock
Retained Earnings (Accumulated Deficit)
Total Shareholders’ Equity
Total Shareholders’ Equity
Conversion of Class C Common Stock to Class A Common Stock
Non-controlling Interest
Non-controlling Interest
Conversion of Class C Common Stock to Class A Common Stock
Common shares outstanding at beginning of period (in shares) at Dec. 31, 2019       280,650,000     1,034,000              
Balance at beginning of period at Dec. 31, 2019 $ 3,270,701     $ 28     $ 0 $ 2,975,756   $ 282,336 $ 3,258,120   $ 12,581  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Restricted stock issued (in shares)       1,305,000                    
Restricted stock forfeited (in shares)       (406,000)                    
Restricted stock used for tax withholding (in shares)       (78,000)                    
Restricted stock used for tax withholding (208)             (208)     (208)      
Issuance of Class A common stock under Employee Stock Purchase Plan (in shares)       59,000                    
Issuance of Class A common stock under Employee Stock Purchase Plan 230             230     230      
Stock-based compensation - equity awards 6,409             6,409     6,409      
Net income (loss) (550,345)                 (547,983) (547,983)   (2,362)  
Common shares outstanding at end of period (in shares) at Mar. 31, 2020       281,530,000     1,034,000              
Balance at end of period at Mar. 31, 2020 2,726,787     $ 28     $ 0 2,982,187   (265,647) 2,716,568   10,219  
Common shares outstanding at beginning of period (in shares) at Dec. 31, 2019       280,650,000     1,034,000              
Balance at beginning of period at Dec. 31, 2019 3,270,701     $ 28     $ 0 2,975,756   282,336 3,258,120   12,581  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income (loss) (545,015)                          
Common shares outstanding at end of period (in shares) at Jun. 30, 2020       282,209,000     0              
Balance at end of period at Jun. 30, 2020 2,734,543     $ 28     $ 0 2,994,832   (260,317) 2,734,543   0  
Common shares outstanding at beginning of period (in shares) at Mar. 31, 2020       281,530,000     1,034,000              
Balance at beginning of period at Mar. 31, 2020 2,726,787     $ 28     $ 0 2,982,187   (265,647) 2,716,568   10,219  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Restricted stock issued (in shares)       80,000                    
Restricted stock forfeited (in shares)       (352,000)                    
Restricted stock used for tax withholding (in shares)       (83,000)                    
Restricted stock used for tax withholding (93)     $ 0       (93)     (93)      
Stock-based compensation - equity awards 4,727             4,727     4,727      
Stock Issued During Period, Value, Conversion of Convertible Securities   $ (2,208)   $ 0         $ (8,011)     $ (8,011)   $ (10,219)
Conversion of common shares from Class C to Class A, net of tax (in shares)         (1,034,000) (1,034,000)                
Net income (loss) 5,330                 5,330 5,330   0  
Common shares outstanding at end of period (in shares) at Jun. 30, 2020       282,209,000     0              
Balance at end of period at Jun. 30, 2020 2,734,543     $ 28     $ 0 2,994,832   (260,317) 2,734,543   0  
Common shares outstanding at beginning of period (in shares) at Dec. 31, 2020     278,551,901 290,646,000                    
Balance at beginning of period at Dec. 31, 2020 2,603,961     $ 29       3,004,433   (400,501) 2,603,961   0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Restricted stock forfeited (in shares)       (1,000)                    
Restricted stock used for tax withholding (in shares)       (128,000)                    
Restricted stock used for tax withholding (477)             (477)     (477)      
Issuance of Class A common stock under Employee Stock Purchase Plan (in shares)       276,000                    
Issuance of Class A common stock under Employee Stock Purchase Plan 167             167     167      
Stock-based compensation - equity awards 4,585             4,585     4,585      
Capped call premiums (14,688)             (14,688)     (14,688)      
Net income (loss) (34,645)                 (34,645) (34,645)      
Common shares outstanding at end of period (in shares) at Mar. 31, 2021       290,793,000                    
Balance at end of period at Mar. 31, 2021 2,558,903     $ 29       2,994,020   (435,146) 2,558,903   0  
Common shares outstanding at beginning of period (in shares) at Dec. 31, 2020     278,551,901 290,646,000                    
Balance at beginning of period at Dec. 31, 2020 $ 2,603,961     $ 29       3,004,433   (400,501) 2,603,961   0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Option exercises (in shares) 14,999                          
Net income (loss) $ (59,700)                          
Common shares outstanding at end of period (in shares) at Jun. 30, 2021     279,219,513 290,801,000                    
Balance at end of period at Jun. 30, 2021 2,538,344     $ 29       2,998,516   (460,201) 2,538,344   0  
Common shares outstanding at beginning of period (in shares) at Mar. 31, 2021       290,793,000                    
Balance at beginning of period at Mar. 31, 2021 2,558,903     $ 29       2,994,020   (435,146) 2,558,903   0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Restricted stock forfeited (in shares)       (7,000)                    
Stock Issued During Period, Value, Stock Options Exercised 15     $ 0       15     15      
Option exercises (in shares)       15,000                    
Stock-based compensation - equity awards 4,481             4,481     4,481      
Net income (loss) (25,055)                 (25,055) (25,055)   0  
Common shares outstanding at end of period (in shares) at Jun. 30, 2021     279,219,513 290,801,000                    
Balance at end of period at Jun. 30, 2021 $ 2,538,344     $ 29       $ 2,998,516   $ (460,201) $ 2,538,344   $ 0